132 related articles for article (PubMed ID: 18841032)
1. Procarbazine and CCNU as initial treatment in gliomatosis cerebri.
Glas M; Rasch K; Wiewrodt D; Weller M; Herrlinger U
Oncology; 2008; 75(3-4):182-5. PubMed ID: 18841032
[TBL] [Abstract][Full Text] [Related]
2. NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.
Glas M; Bähr O; Felsberg J; Rasch K; Wiewrodt D; Schabet M; Simon M; Urbach H; Steinbach JP; Rieger J; Fimmers R; Bamberg M; Nägele T; Reifenberger G; Weller M; Herrlinger U;
Ann Neurol; 2011 Sep; 70(3):445-53. PubMed ID: 21710625
[TBL] [Abstract][Full Text] [Related]
3. Initial chemotherapy in gliomatosis cerebri.
Sanson M; Cartalat-Carel S; Taillibert S; Napolitano M; Djafari L; Cougnard J; Gervais H; Laigle F; Carpentier A; Mokhtari K; Taillandier L; Chinot O; Duffau H; Honnorat J; Hoang-Xuan K; Delattre JY;
Neurology; 2004 Jul; 63(2):270-5. PubMed ID: 15277619
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
[TBL] [Abstract][Full Text] [Related]
5. Gliomatosis cerebri: treatment results with radiotherapy alone.
Elshaikh MA; Stevens GH; Peereboom DM; Cohen BH; Prayson RA; Lee SY; Barnett GH; Suh JH
Cancer; 2002 Nov; 95(9):2027-31. PubMed ID: 12404298
[TBL] [Abstract][Full Text] [Related]
6. [Gliomatosis cerebri: report of 3 cases and review of recent literatures].
Arai M; Kashihara K; Kaizaki Y; Taguchi M; Kitamura Y
No To Shinkei; 2003 Oct; 55(10):890-7. PubMed ID: 14635518
[TBL] [Abstract][Full Text] [Related]
7. Patterns of presentation and failure in patients with gliomatosis cerebri treated with partial-brain radiation therapy.
Kandula S; Saindane AM; Prabhu RS; Hanasoge S; Patel KR; Shu HK; Curran WJ; Crocker IR
Cancer; 2014 Sep; 120(17):2713-20. PubMed ID: 24845411
[TBL] [Abstract][Full Text] [Related]
8. Gliomatosis cerebri treatment in 11 elderly patients.
Piccirilli M; Landi A; Salvati M
J Exp Clin Cancer Res; 2006 Jun; 25(2):183-7. PubMed ID: 16918128
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.
Abrey LE; Childs BH; Paleologos N; Kaminer L; Rosenfeld S; Salzman D; Finlay JL; Gardner S; Peterson K; Hu W; Swinnen L; Bayer R; Forsyth P; Stewart D; Smith AM; Macdonald DR; Weaver S; Ramsay DA; Nimer SD; DeAngelis LM; Cairncross JG
Neuro Oncol; 2006 Apr; 8(2):183-8. PubMed ID: 16524945
[TBL] [Abstract][Full Text] [Related]
10. PCV chemotherapy for recurrent glioblastoma.
Schmidt F; Fischer J; Herrlinger U; Dietz K; Dichgans J; Weller M
Neurology; 2006 Feb; 66(4):587-9. PubMed ID: 16505319
[TBL] [Abstract][Full Text] [Related]
11. Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri.
Kaloshi G; Guillevin R; Martin-Duverneuil N; Laigle-Donadey F; Psimaras D; Marie Y; Mokhtari K; Hoang-Xuan K; Delattre JY; Sanson M
Neurology; 2009 Aug; 73(6):445-9. PubMed ID: 19667319
[TBL] [Abstract][Full Text] [Related]
12. Gliomatosis cerebri: 20 years of experience at the Children's Hospital of Philadelphia.
Armstrong GT; Phillips PC; Rorke-Adams LB; Judkins AR; Localio AR; Fisher MJ
Cancer; 2006 Oct; 107(7):1597-606. PubMed ID: 16955507
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma.
Yamamoto M; Iwaasa M; Nonaka M; Tsugu H; Nabeshima K; Fukushima T
Anticancer Res; 2005; 25(6A):3715-23. PubMed ID: 16302731
[TBL] [Abstract][Full Text] [Related]
14. Impact of adjuvant chemotherapy for gliomatosis cerebri.
Kong DS; Kim ST; Lee JI; Suh YL; Lim DH; Kim WS; Kwon KH; Park K; Kim JH; Nam DH
BMC Cancer; 2010 Aug; 10():424. PubMed ID: 20704759
[TBL] [Abstract][Full Text] [Related]
15. Gliomatosis cerebri having a poor performance status without recurrence after radiotherapy: a single institutional experience.
Jung TY; Yoon MS; Kim YH; Jung S; Kim IY; Jang WY; Moon KS; Lee KH; Kim SK
Clin Neurol Neurosurg; 2015 Mar; 130():1-5. PubMed ID: 25569296
[TBL] [Abstract][Full Text] [Related]
16. [Gliomatosis cerebri: review of 22 patients].
Novillo López ME; Gómez-Ibáñez A; Rosenfeld M; Dalmau J
Neurologia; 2010 Apr; 25(3):168-73. PubMed ID: 20492863
[TBL] [Abstract][Full Text] [Related]
17. Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.
Glas M; Hundsberger T; Stuplich M; Wiewrodt D; Kurzwelly D; Nguyen-Huu B; Rasch K; Herrlinger U
Oncology; 2009; 76(3):184-9. PubMed ID: 19218824
[TBL] [Abstract][Full Text] [Related]
18. [Gliomatosis cerebri].
Sanson M; Napolitano M; Cartalat-Carel S; Taillibert S
Rev Neurol (Paris); 2005 Feb; 161(2):173-81. PubMed ID: 15798516
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study.
Brandes AA; Tosoni A; Vastola F; Pasetto LM; Coria B; Danieli D; Iuzzolino P; Gardiman M; Talacchi A; Ermani M
Cancer; 2004 Nov; 101(9):2079-85. PubMed ID: 15372474
[TBL] [Abstract][Full Text] [Related]
20. Gliomatosis cerebri: better definition, better treatment.
Chamberlain MC
Neurology; 2004 Jul; 63(2):204-5. PubMed ID: 15277608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
